My basic calcs:
Revenue from Domantis sale: $170M
Estimated royalty revenues next 4 years: $100M
Cash on hand: $42M
Total: $312M
Total Shares on Issue: 164M
$/Share: $1.90
This is without attributing any value to their portfolio of promising big $ potential research projects.
Am I missing something? Seems cheap to me!
PTD
unknown
